BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23267058)

  • 1. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
    Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.
    Yang X; Zhang Y; Yang Y; Lim S; Cao Z; Rak J; Cao Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13932-7. PubMed ID: 23918367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental growth factor upregulation is a host response to antiangiogenic therapy.
    Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA
    Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.
    Park I; Yang H; Park JS; Koh GY; Choi EK
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):609-618. PubMed ID: 30017791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PlGF blockade does not inhibit angiogenesis during primary tumor growth.
    Bais C; Wu X; Yao J; Yang S; Crawford Y; McCutcheon K; Tan C; Kolumam G; Vernes JM; Eastham-Anderson J; Haughney P; Kowanetz M; Hagenbeek T; Kasman I; Reslan HB; Ross J; Van Bruggen N; Carano RA; Meng YJ; Hongo JA; Stephan JP; Shibuya M; Ferrara N
    Cell; 2010 Apr; 141(1):166-77. PubMed ID: 20371352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
    Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
    Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
    Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
    Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes.
    Freitas-Andrade M; Carmeliet P; Stanimirovic DB; Moreno M
    J Neurochem; 2008 Nov; 107(3):756-67. PubMed ID: 18786179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.
    Hwang JE; Lee JH; Park MR; Kim DE; Bae WK; Shim HJ; Cho SH; Chung IJ
    Yonsei Med J; 2013 Mar; 54(2):374-80. PubMed ID: 23364970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
    Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
    Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sFLT01: a novel fusion protein with antiangiogenic activity.
    Bagley RG; Kurtzberg L; Weber W; Nguyen TH; Roth S; Krumbholz R; Yao M; Richards B; Zhang M; Pechan P; Schmid S; Scaria A; Kaplan J; Teicher BA
    Mol Cancer Ther; 2011 Mar; 10(3):404-15. PubMed ID: 21252283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.
    Incio J; Tam J; Rahbari NN; Suboj P; McManus DT; Chin SM; Vardam TD; Batista A; Babykutty S; Jung K; Khachatryan A; Hato T; Ligibel JA; Krop IE; Puchner SB; Schlett CL; Hoffmman U; Ancukiewicz M; Shibuya M; Carmeliet P; Soares R; Duda DG; Jain RK; Fukumura D
    Clin Cancer Res; 2016 Jun; 22(12):2993-3004. PubMed ID: 26861455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
    Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
    Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
    Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.